These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2370929)

  • 1. Effect of serum urokinase on urine fibrinolytic activity.
    Hong SY; Pyo SJ; Lee HB
    Nephron; 1990; 55(3):287-91. PubMed ID: 2370929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal polypeptide (VIP) stimulates fibrinolytic system in the rat.
    Hagiwara M; Hongo K; Morikawa T
    Jpn J Pharmacol; 1990 Sep; 54(1):86-8. PubMed ID: 2273652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained fibrinolytic activity in the euglobulin fraction induced by concomitant administration of urokinase and dextran sulphate.
    Matsuo O; Kawaguchi T; Kosugi T; Mihara H
    Thromb Res; 1978 Dec; 13(6):1125-30. PubMed ID: 749265
    [No Abstract]   [Full Text] [Related]  

  • 4. A delaying influence of cryoglobulins in the assessment of euglobulin fibrinolytic activity.
    Gram J; Jespersen J; Astrup T
    Thromb Res; 1986 Mar; 41(6):781-9. PubMed ID: 2422781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic activity in end-stage renal disease.
    Hong SY; Yang DH
    Nephron; 1993; 63(2):188-92. PubMed ID: 8450911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urokinase concentration in the renal artery and vein.
    Hong SY; Yang DH; Kim PN
    Nephron; 1992; 61(2):176-80. PubMed ID: 1630542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
    Jespersen J; Kluft C
    Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic activity in healthy volunteers before and after 5 to 20 minutes of venous occlusion.
    Bauer J; Bachmann F
    Thromb Res; 1984 Apr; 34(2):159-74. PubMed ID: 6539514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excessive urokinase-type plasminogen activator activity in the euglobulin fraction of patients with Alzheimer-type dementia.
    Alonso DF; Farias EF; Famulari AL; Dominguez RO; Kohan S; de Lustig ES
    J Neurol Sci; 1996 Jul; 139(1):83-8. PubMed ID: 8836977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of furosemide on plasma fibrinolytic activity and urokinase excretion.
    Chohan IS; Singh I; Vermylen J; Verstraete M
    Exp Hematol; 1977 Mar; 5(2):153-7. PubMed ID: 844519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.
    Kluft C; Wijngaards G; Jie AF
    J Lab Clin Med; 1984 Mar; 103(3):408-19. PubMed ID: 6199446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of urokinase inhibitors on effective fibrinolytic activity of human urine].
    Potapenko VE; Shataeva LK
    Vopr Med Khim; 1994; 40(1):37-8. PubMed ID: 8122409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic fibrinolytic activity and inhibitor levels during treatment of deep vein thrombosis with urokinase and streptokinase.
    Theiss W; Asbeck F; Kriessmann A; Trübestein G; Knoch K; de Swart CA; Marbert GA; van de Loo JC
    Thromb Haemost; 1983 Oct; 50(3):664-8. PubMed ID: 6196852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV; Andreenko GV; Poliantseva LR; Bumblite ID
    Vopr Med Khim; 1999; 45(2):158-64. PubMed ID: 10378306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between gender difference in intravascular aggregation of platelets and the fibrinolytic pathway in the rat.
    Oyekan AO; Botting JH
    Arch Int Pharmacodyn Ther; 1991; 313():176-92. PubMed ID: 1816761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.